Navigation Links
Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011
Date:5/25/2011

ded.

Fiscal Fourth Quarter and Full Year Results for the Period Ended March 31, 2011 Net sales for the fiscal fourth quarter ended March 31, 2011 totaled $4.0 million, an increase of 35% over net sales of $3.0 million for the year-ago quarter.  Fiscal year 2011 net sales were $13.8 million, a 16% increase over fiscal 2010 sales of $11.9 million.  Excluding the impact of foreign exchange translation, sales grew by 19%.

Sales to customers in the U.S. for the fiscal fourth quarter ended March 31, 2011 were $2.4 million, a 54% increase, compared to $1.6 million in the year-ago quarter, and an increase of 21% over fiscal third quarter sales of $2.0 million.  In fiscal 2011, sales to customers in the U.S. totaled $7.9 million, representing a 31% increase over sales of $6.1 million in fiscal 2010.  

Sales in the U.S. of the Urgent PC product for the fiscal fourth quarter ended March 31, 2011 increased 43% to $1.3 million compared with $909,000 for the same period last year and an increase of  26% over fiscal third quarter sales of $1 million.  The Company sold 1,668 Urgent PC lead set boxes to 346 customers in the fiscal fourth quarter ended March 31, 2011 compared to 1,379 boxes to 236 customers in the third fiscal quarter ended December 31, 2010.  The increase in sequential sales of lead set boxes and number of customers in the fourth fiscal quarter is attributable primarily to the listed CPT code assigned effective January 2011 and expanded third-party coverage for PTNS treatments.  For fiscal 2011, Urgent PC sales totaled $4.3 million, representing an increase of 11%, over sales of $3.8 million in fiscal 2010.  

Sales in the U.S. of Macroplastique increased 60% to $1.0 million for the fiscal fourth quarter ended March 31, 2011, from $654,000 for the same period last year.  Fiscal 2011 sales of Macroplastique increased 60% to $3.5 million compared with $2.2 million in fiscal 2010.

Ne
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Uroplasty to Present at the JMP Securities Research Conference
2. Clinical Studies Results of Uroplasty Products Scheduled for Presentation at Three Professional Meetings
3. Uroplasty Announces Expanded Insurance Coverage of Posterior Tibial Nerve Stimulation (PTNS) Delivered Using the Urgent® PC Neuromodulation System
4. Uroplasty to Present at ROTH Capital Partners 23rd Annual OC Growth Stock Conference
5. Uroplasty Reports Financial Results for the Third Quarter FY2011
6. Uroplasty to Issue Third Quarter 2011 Results on January 27, 2011
7. Uroplasty Announces Addition of Robert Kill to its Board of Directors
8. Additional Regional Medicare Carrier Initiates Coverage for Posterior Tibial Nerve Stimulation (PTNS) Delivered via Uroplastys Urgent® PC Neuromodulation System
9. Uroplasty Inc. Announces CPT® Category I Code and Associated Reimbursement Value for Posterior Tibial Nerve Stimulation
10. Uroplasty Reports Financial Results for the Second Quarter FY2011
11. Uroplasty to Issue Second Quarter 2011 Results on October 27, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its ... highly sophisticated agro-breeding solutions for plant breeders and researchers, ... board of directors appointed chemistry and pharmaceutical industry expert ... of the board. From 1975 to 2012, ...
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Nov. 8, 2011 MedBox (Pink Sheets: ... have changed their ticker symbol to MDBX.  The company ... to MedBox. The company is a ... dispensing systems of prescription medicines. The free-standing unit features ...
... 8, 2011 Reportlinker.com announces that a ... its catalogue: European Markets ... http://www.reportlinker.com/p0681077/European-Markets-for-Ophthalmic-Devices-2011-Diagnostic--Invasive.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Ophthalmic_Devices ... interventional ophthalmic device market was valued at ...
Cached Medicine Technology:MedBox Announces Ticker Symbol Change 2European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 2European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 3European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 4European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 5European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 6European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 7European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 8European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 9European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 10European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 11European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 12European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 13European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 14European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 15European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 16European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 17European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 18European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 19European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 20European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 21
(Date:4/17/2014)... is less than 40 years away from a food ... governments, according to a top scientist at the U.S. ... human history, food production will be limited on a ... energy," said Dr. Fred Davies, senior science advisor for ... become as politically destabilizing by 2050 as energy issues ...
(Date:4/17/2014)... they suffer a cardiac arrest outside of a hospital ... to new research conducted at St. Michael,s Hospital. , ... arrest get adrenaline, which has been the drug recommended ... Lin, an emergency physician and trauma team leader at ... survival rates of patients who suffer a cardiac outside ...
(Date:4/17/2014)... have called for more research to be carried ... in sub-Saharan Africa. In a paper in ... Stothard, working with colleagues in the department of ... in Cleveland Ohio, University of Cambridge and the ... the joint burden of HIV/AIDS and schistosomiasis of ...
(Date:4/16/2014)... (April 16, 2014): Celldex Therapeutics, Inc. (NASDAQ: CLDX) ... study of CDX-1401 in solid tumors, including long-term patient ... (Vol 6 Issue 232). The data demonstrate robust ... benefit in patients with very advanced cancers and suggest ...
(Date:4/16/2014)... it is well known that fertility treatments are the ... multiples are at elevated risk of premature birth, these ... Fertility and Sterility . The article identifies ... the odds of multiple births and prematurity, including expanding ...
Breaking Medicine News(10 mins):Health News:Food shortages could be most critical world issue by mid-century 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3
... maintain safe driving habits starts at home with open ... past Liberty Mutual/SADD research, teens of parents who establish ... are less likely to drive under the influence of ... percent vs. 56 percent) than those without set consequences. ...
... Bermuda, Oct. 19 Allied World,Assurance Company Holdings, Ltd ... Susan Chmieleski, Senior Vice President, Healthcare Product & Risk,Management, ... and Risk,Management (ASHRM) annual conference in Denver, Colorado on ... Does Your Risk Program,Work?, , ...
... researchers say , MONDAY, Oct. 19 (HealthDay News) -- ... disease (IBD) increases the risk of cancers related to ... includes Crohn,s disease and ulcerative colitis. Thiopurine drugs are ... maintain remission in IBD patients. , For this study, ...
... 19 According to Google Trends ( www.google.com/trends/hottrends?q=the+cookie+diet&date=2009-10-16&sa=X ... ranking of the 40 most-searched terms on the Google ... sixth most-searched term last Friday. The highest ranking term ... boy throws up" which ranked a distant fifteenth. ...
... year of life, nutrition is critical to establishing a foundation ... time, a collection of visual images that tell the story ... growth and development during that critical first twelve months will ... go to: http://multivu.prnewswire.com/mnr/enfamil/40064/ , This ...
... ... for healthcare claims in response to the skyrocketing overpayment recoupment dispute and ... hospitals were told by insurance Co.,s and payers, on every EOB, to ... providers knew how to, as there has been very little resource available ...
Cached Medicine News:Health News:Liberty Mutual Teen Driving Website Offers New Family Communication Tools to Promote Driving Safety 2Health News:Liberty Mutual Teen Driving Website Offers New Family Communication Tools to Promote Driving Safety 3Health News:Allied World's Susan Chmieleski to Speak at American Society for Healthcare Risk Management (ASHRM) Annual Conference and Exhibition 2Health News:Allied World's Susan Chmieleski to Speak at American Society for Healthcare Risk Management (ASHRM) Annual Conference and Exhibition 3Health News:Drugs for Irritable Bowel Might Increase Cancer Risk 2Health News:Dr. Siegal's Cookie Diet Beats 'Balloon Boy' Story on Google's Most-Searched Topics List 2Health News:Dr. Siegal's Cookie Diet Beats 'Balloon Boy' Story on Google's Most-Searched Topics List 3Health News:Photos: First-of-Its-Kind Website Unveiled at 'Modern Moms Meet Modern Science' Meeting 2Health News:ERISAclaim.com Announced Free ERISA Webinar for Healthcare Overpayment Dispute and Claim Denials in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 2Health News:ERISAclaim.com Announced Free ERISA Webinar for Healthcare Overpayment Dispute and Claim Denials in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 3Health News:ERISAclaim.com Announced Free ERISA Webinar for Healthcare Overpayment Dispute and Claim Denials in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 4
Steroid-eluting, single-pass lead. CapSure VDD2 optimizes VDD therapy and offers easier handling, proven performance, and choice....
Steroid eluting pacemaker leads with preformed J...
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Medicine Products: